Mckesson Orasol Gel
NDC Package 68599-8247-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mckesson Orasol Gel (benzocaine 20%) gel is usesFor the temporary relief of minor pain and sore mouth associated with toothache, minor dental procedures and irritations from dentures or orthodontic appliances. This formulation utilizes a gel delivery system. Marketed by Mckesson Medical-surgical, this product is identified by NDC 68599-8247 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
68599-8247-4
Package Description
75 PACKET in 1 BOX / .75 g in 1 PACKET
Product Code
68599-8247
11-Digit Billing Format
68599824704
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Mckesson Orasol Gel
Non-Proprietary Name
Benzocaine 20%
Substance Name
Benzocaine
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZOCAINE 200 mg/g
Pharmacologic Class
Usage Information
UsesFor the temporary relief of minor pain and sore mouth associated with toothache, minor dental procedures and irritations from dentures or orthodontic appliances.

Regulatory & Marketing

Labeler Name
Mckesson Medical-surgical
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-04-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68599-8247-4 identifies a specific commercial package of 75 packet in 1 box / .75 g in 1 packet of Mckesson Orasol Gel, a human over the counter drug labeled by Mckesson Medical-surgical. This gel is formulated for topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson Medical-surgical on October 04, 2021. The current certification is valid through December 31, 2026.

How is this Mckesson Medical-surgical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68599824704. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68599-8247-4
11-Digit CMS (5-4-2)
68599-8247-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.